CAMBRIDGE, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today announced that its presentation at the 2007 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference will be webcast live and may be accessed by visiting the Investors section of the Company’s website, www.millennium.com. The Company’s year-end financial results for 2006 will be issued in a press release on February 8, 2007, in conjunction with this conference.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
Dr. Deborah Dunsire, president and chief executive officer of Millennium and Marsha Fanucci, chief financial officer and senior vice president, corporate strategy, will discuss the Company’s 2006 financial results as well as goals and financial guidance for 2007. The presentation will be delivered at 8:00 a.m. ET on Thursday, February 8, 2007 from The Grand Hyatt Hotel in New York, NY. The presentation will be archived for 30 days on the Company’s website www.millennium.com.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company’s research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company’s website is www.millennium.com.
Editors’ Note: This press release is also available under the Media section of the Company’s website at: www.millennium.com.
Contact:
Kyle Kuvalanka
(617)761-4734
Photo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comMillennium Pharmaceuticals, Inc.
CONTACT: Kyle Kuvalanka of Millennium Pharmaceuticals, Inc.,+1-617-761-4734
Web site: http://www.millennium.com/
Company News On-Call: http://www.prnewswire.com/comp/114562.html /
